Investors Home
| Amsterdam Molecular Therapeutics (Euronext: AMT) is a leading gene therapy company, with a unique platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy to become a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform.More » | More » |
| Recent News |
|
Upcoming Events
|
|
